Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
about
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implicationB-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancerDown regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynxDifferential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas.BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.Expression of B-cell-specific Moloney murine leukemia virus integration site 1 mRNA and protein in gastric cancer.BMI-1, a promising therapeutic target for human cancer.miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.Overexpression and lack of copy number variation in the BMI-1 gene in human gliomaERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer.Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status.Cancer Stem Cell Signaling during Repopulation in Head and Neck Cancer.Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets.Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysisTargeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients.Association of BMI-1 and p16 as prognostic factors for head and neck carcinomas.Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.Expression of BMI1 and p16 in laryngeal squamous cell carcinoma.Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma.Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation.Markers of Oral Lichen Planus Malignant Transformation.Radiosensitizing and Hyperthermic Properties of Hyaluronan Conjugated, Dextran-Coated Ferric Oxide Nanoparticles: Implications for Cancer Stem Cell Therapy
P2860
Q26745972-E63CB2D7-E76F-4F26-8BFE-FA7F67F820BAQ28075362-DE310AC5-1B62-40AC-B767-4E8C4BD1B45AQ33922345-F1E095C1-43C1-418F-B0E1-56DB704C2855Q34464484-ADC9707A-C32A-4F82-965A-DBF562848915Q34720367-20FDB3C1-5FA3-4912-8B16-1BC366D50579Q35083849-1400A862-6578-4196-869B-0158AFB57E1CQ35870390-1EBEB323-74F2-4CBE-A3A2-0FD5FBAADDF7Q36135379-E020548B-36BC-43E2-905B-4F790EA60EE2Q36336437-56FE42C3-E68C-4D08-BA7E-BEA76F3BA730Q36356437-6774C309-7D92-4D28-9D00-AD3C7F9FE599Q36406823-8BDDEFF0-8DB2-4996-8D75-155CE583C273Q36531535-14C18B04-ABE4-49A9-B686-7F84A4D37900Q36962691-8DB6BAF8-6A1F-4E39-99B2-4F41EAFB48B8Q37615798-F9C839C4-6D21-46D5-B010-282208F035B1Q37655038-824F3003-7BA7-422D-899B-2F9B8813C30CQ38793389-31AA6ECE-DBC6-4EAB-96FA-5A2B13AFE052Q40725395-CD1FCAE1-E6B0-424C-8DA3-9AEA69E3AB1DQ41040518-8F1006C9-F268-4EFB-A058-9692A49F3D5DQ43615379-C31CA8FE-205E-4E47-ABFA-30C5E94AC47EQ47102136-1717D577-56C8-42A0-9071-6748D5BCE67CQ52431796-A4DA64A6-3B69-4236-B023-71F25905FFDCQ52685800-316AD925-1E69-4E9D-8933-B1B568653277Q55041964-0CC953AB-D226-4853-927D-70199EB886D5Q59113724-7EA3546E-3E8E-48B9-89F2-1E7A20E970D4
P2860
Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Expression patterns of Bmi-1 a ...... ngeal squamous cell carcinoma.
@en
Expression patterns of Bmi-1 a ...... ngeal squamous cell carcinoma.
@nl
type
label
Expression patterns of Bmi-1 a ...... ngeal squamous cell carcinoma.
@en
Expression patterns of Bmi-1 a ...... ngeal squamous cell carcinoma.
@nl
prefLabel
Expression patterns of Bmi-1 a ...... ngeal squamous cell carcinoma.
@en
Expression patterns of Bmi-1 a ...... ngeal squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Expression patterns of Bmi-1 a ...... yngeal squamous cell carcinoma
@en
P2093
Alex Soltermann
Andrea Albinger-Hegyi
Gerhard F Huber
Holger Moch
Ivan Hegyi
Matthias Roessle
Nicole Graf
Stephan K Haerle
P2860
P304
P356
10.1002/CNCR.26100
P407
P577
2011-03-29T00:00:00Z